IMMUNEPOTENT CRP plus doxorubicin/cyclophosphamide chemotherapy remodel the tumor microenvironment in an air pouch triple-negative breast cancer murine model-Reference-Cited by-同舟云学术

IMMUNEPOTENT CRP plus doxorubicin/cyclophosphamide chemotherapy remodel the tumor microenvironment in an air pouch triple-negative breast cancer murine model

Published:2020-06 Issue: Volume:126 Page:110062
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Santana-Krímskaya Silvia Elena,Franco-Molina Moisés Armides,Zárate-Triviño Diana Ginette,Prado-García Heriberto,Zapata-Benavides Pablo,Torres-del-Muro Felipe,Rodríguez-Padilla Cristina

Funder

Laboratorio de Inmunología y Virología de la Universidad Nacional Autónoma de Nuevo León, México

Fondo Sectorial de Investigación para la Educación

CONACYT, México

LONGEVEDEN S.A de C.V

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference44 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

2. Role of natural herbs and phytochemicals to minimize tumor and economic burden in breast cancer treatment;Shoaib;Breast Cancer Targets Ther.,2016